. Sodium Phenylbutyrate and Ursodoxicoltaurine: First Approval. CNS Drugs. 2022 Sep;36(9):1007-1013. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.